Cleared Traditional

K812036 - NEUROGAR III

K812036 is an FDA 510(k) clearance for NEUROGAR III, manufactured by Inter Med Industries, Inc.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 18-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1981
Decision
18d
Days
Class 2
Risk

K812036 is an FDA 510(k) clearance for the NEUROGAR III. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Inter Med Industries, Inc. (Mchenry, US). The FDA issued a Cleared decision on August 7, 1981 after a review of 18 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K812036

510(k) Number K812036 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 20, 1981
Decision Date August 07, 1981
Days to Decision 18 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
131d faster than avg
Panel avg: 149d · This submission: 18d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 605
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K812036.
NEUROMED SELECTRA #7720
K812704 · Medtronic Vascular · Oct 1981
TENSMAX
K811499 · Anritsu America Co. · Aug 1981
TENS DEVICE
K812138 · Western Advanced Technology, Inc. · Aug 1981
VERI-FIER
K811351 · Verite · Jul 1981
VITATRON 88
K811939 · Vitatronics · Jul 1981
INSIGHT
K811345 · Staodynamics, Inc. · Jul 1981